|
|
||||||||


*
The Department of Clinical Immunology and Centre for Transfusion Medicine and Immunology, Flinders Medical Centre, Bedford Park, South Australia; and
Chiron Mimotopes, Clayton,
The Biomolecular Research Institute, Parkville,
§
School of Chemical Sciences, Swinburne University of Technology, Hawthorn, and
¶
The Department of Microbiology, University of Melbourne, Parkville, Victoria, Australia
In studying the CTL recognition of peptide determinants derived
from the nuclear Ag La (SS-B), we observed significant skewing of the
response toward rare components present within the immunogen. Thus,
priming of naive mouse lymphocytes in vitro with a synthetic
H-2Kb-binding peptide comprising human La (hLa)
residues 5158 resulted in class I-restricted cytotoxic T cells that
failed to recognize naturally presented hLa 5158 peptide. Instead,
the majority of T hybrids recognized a low abundance (
1%)
contaminant present at picomolar concentrations in the original
synthesis and identified as a peptide adduct containing
N,4-t-butyl asparagine at position 6 of the hLa
5158 sequence. The preferred T cell recognition of the butyl adduct
was not due to increased affinity of this peptide for the
H-2Kb molecule or to the antagonism of CTL recognizing the
unmodified determinant. Rather, the bias in the immune response
appeared to be the result of partial self-tolerance to the homologous
mouse La 5158 determinant, which differs from its human counterpart
by only a single amino acid at position 1 (T
I). Accordingly, the CTL
response appeared to be focused on "non-self" ligands present
within the synthesis, even though they were present at very low
concentrations. These observations have significant implications for
the use of synthetic peptide vaccines, especially those designed to
manipulate responses to self peptides such as tumor Ags in which
self-tolerance may result in unexpected reactivity.
This article has been cited by other articles:
![]() |
A. W. Purcell and J. J. Gorman Immunoproteomics: Mass Spectrometry-based Methods to Study the Targets of the Immune Response Mol. Cell. Proteomics, March 1, 2004; 3(3): 193 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Lovitch, J. J. Walters, M. L. Gross, and E. R. Unanue APCs Present A{beta}k-Derived Peptides That Are Autoantigenic to Type B T Cells J. Immunol., April 15, 2003; 170(8): 4155 - 4160. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |